Clinical trials of TB vaccine for adults start in India

Tribune News Service

Updated At : 12:31 PM Mar 25, 2024 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi: Bharat Biotech has begun the clinical trials for tuberculosis (TB) vaccine MTBVAC on adults in India. Developed by Spanish biopharmaceutical company Biofabri, the MTBVAC is the first vaccine against TB derived from a human source. TNS

Left stomps ABVP’s hopes, wins all JNUSU posts

new delhi: The United Left panel effected a clean sweep in the Jawaharlal Nehru University Students’ Union election, defeating its nearest rival the RSS-affiliated ABVP on Sunday. Dhananjay won the president’s post by securing 2,598 votes.

Tags :

Bharat

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles